Stereotaxis

STXSNYSE United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$104.220 M

$1.04 +8.66%

Close of 6 Nov 2026

As of 6 Nov 2026, Stereotaxis (STXS) has a market capitalization of $104.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$32.4M

#2843 by revenue

Earnings

-$21.6M

Loss-making

Shares outstanding

100,202,178

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#11Edap TmsFOCL$192.5M
#12SolanaHSDT$124.1M
#13StereotaxisSTXS$104.2M
#14Vivani MedicalVANI$94.7M
#15electroCoreECOR$82.0M

What if Stereotaxis were worth as much as…

Open the what-if tool →

Gold $28.2T

$281,799.00

Per share 270,935× higher

Bitcoin $1.53T

$15,247.65

Per share 14,660× higher

Apple $5.02T

$50,056.62

Per share 48,127× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Stereotaxis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.